An antigen-specific signal is required for the activation of second- order suppressor T cells in the regulation of delayed-type hypersensitivity to 2,4,6-trinitrobenzene sulfonic acid by unknown
AN ANTIGEN-SPECIFIC  SIGNAL IS REQUIRED  FOR THE 
ACTIVATION  OF SECOND-ORDER  SUPPRESSOR  T  CELLS  IN 
THE  REGULATION  OF DELAYED-TYPE  HYPERSENSITIVITY 
TO  2,4,6-TRINITROBENZENE  SULFONIC  ACID 
BY  MAKOTO  TSURUFUJI,*  BARUJ  BENACERRAF,  AND MAN-SUN  SY* 
From the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 
The interaction of multiple T  cell subsets, in the down regulation of antigen- 
specific immune responses, have been demonstrated in many different experi- 
mental models (1,  2).  However, due to the complexity by which the immune 
response is regulated and the 'subtle' variations in the experimental systems of 
different investigators, it has been difficult to compare results and to construct 
a general scheme that will encompass all the published findings. 
Nevertheless,  we  proposed  such a  general  scheme for a  suppressor  T  cell 
pathway based mainly on the results obtained in our laboratories (3), with several 
models  of immune  responses  by  suppressor  T  cells,  including  cell-mediated 
immune response to simple haptens like azobenzenearsonate (ABA)  a (4,  5,  6) 
and 4-hydroxy-3-nitrophenyi acetyl (NP) (7), and humoral immune response to 
the synthetic copolymer of L-glutamic acid-L-alanine-L-tryosine (GAT) (8, 9). 
In our proposed scheme, we postulated that  T  cell-mediated suppression in 
murine system proceeds by a common major pathway involving the sequential 
interaction of three T  ceil subsets, each with distinct properties. We have named 
these three T  cell subsets Ts-1, Ts-2, and Ts-3. 
Based on our studies involving the suppression of delayed-type hypersensitivity 
(DTH) reaction to ABA and NP in mice, we concluded that intravenous injection 
of haptenated  syngeneic spleen  cells  (SC)  triggers  a  population  of relatively 
cyclophosphamide-sensitive pre-Ts-1 cells, which then mature into antigen-reac- 
tive cells, or Ts-1. These Ts-1 cells are Lyt-1 +2- and bear idiotypic determinants 
serologically cross-reactive (CRI) with those present in anti-ABA antibodies of 
appropriate  strains of mice (10).  A  soluble suppressor T  cell factor (TsF-1)  is 
obtained  from  these  Ts-1  cells  or  Ts-1  hybridoma  cells.  Similar  to  Ts-1  in 
receptor specificity, TsF-1 also binds antigen, and bears some CRI determinants. 
TsF-1 induces nonimmune T  cells to become Ts-2. In contrast to Ts-1, Ts-2 are 
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antiidiotypic, Lyt-l+2  + cells, and function as efferent suppressors in the systems; 
for  example,  Ts-2  ceils  are  able  to  suppress  DTH  reaction  at  the  time  of 
elicitation.  Ts-2  cells release  a  soluble factor,  TsF-2,  which  activates the  final 
effector suppressor Ts-3. Ts-3 cells are Lyt-2+3  + and bind antigen. 
In the ABA and NP systems, TsF-1  obtained either from Ts-l-containing  SC 
or  T  cell  hybridoma  can  trigger  Ts-2  cells  in  the  absence  of any  additional 
antigen.  This is in sharp  contrast with our earlier findings in the suppressor T 
cell pathway of GAT and L-glutamic acid-L-tryosine (GT). In the GAT and GT 
systems, antigens are absolutely required for the activation of Ts-2 cells by TsF- 
1 factors (8). It is highly unlikely that this discrepancy arises from differences in 
the  assay systems.  Furthermore,  it  has  been  reported  recently  that  the  Ts-2, 
induced in the presence of antigen in the GT system, is antigen specific rather 
than idiotypic specific (11). The exact reason why in some systems Ts-2 cells are 
antiidiotypic (12,  13,  14,  15), and yet in others they are antigen  specific is not 
clear (11).  It is possible, however, that the antiidiotypic nature of the ABA and 
NP Ts-2 cells and factors is due to the presence of a predominant CRI family in 
these  two  systems  (12,  16).  Since  their  humoral  immune  responses  produce 
antibodies that lack a  major predominant  idiotype (17), systems like GAT may 
require both antigen-specific TsF-1  and an antigen signal to activate Ts-2. 
To further clarify the importance of idiotypic-antiidiotypic interactions in the 
regulation of suppressor T  cell interactions, and the role of antigen in triggering 
Ts-2 cells, in systems lacking major CRI, we investigated the regulation of DTH 
reaction to another simple hapten, trinitrobenzene sulfonic acid (TNBS), a system 
which  has  been  studied  extensively by Asherson  and  Zembala  (18).  Immune 
responses to TNBS lack a  major predominant  idiotype; thus the response pro- 
vides us an opportunity to study the suppressor T  cell pathway in a system where 
antigen, and not idiotypes, may mediate essential suppressor T  cell interactions. 
The major points examined in our studies of suppressor T  cells and their factors 
in the down regulation of DTH response to trinitrophenyl  (TNP) were: (a) the 
binding specificity of the relevant Cells and, in particular, whether their receptors 
are idiotypic (antigen  specific) or antiidiotypic; (b) the antigen requirements for 
the activation  of second-order Ts-2  cells; and  (c) the  mode of action  of these 
suppressor T  cells and their factors. 
Materials and Methods 
Mice.  A/J (H-2R), B10.BR (H-2k), B6 (H-2b), and DBA/2 (H-2  d) mice obtained from 
The Jackson  Laboratory, Bar Harbor,  ME.  BALB/c (H-2  d) mice were obtained from 
Charles River Breeding Laboratories, Inc., Wilmington,  MA. All the animals used in this 
study were maintained in accordance with the guidelines  of the Committee on Animals 
of the Harvard Medical School and those prepared by the Committee on Care and Use 
of Laboratory Animals of the Institute of Laboratory Animal  Resources,  National  Re- 
search Council (DHEW publication NIH 78-23, revised  1978). 
Induction and Elicitation  of DTH to TNP and ABA.  To induce DTH to TNP, 0.2 ml of 
10 mM TNBS pH 7.4 solution was injected subcutaneously into two separate sites on the 
dorsal flanks of the mice. Challenge  was performed 6 d later by injecting  30 ul of 10 mM 
TNBS pH 7.4 solution into the right  footpad. 24 h after the footpad challenge,  DTH 
reactivity was assessed by measuring the swelling of the footpad with a Fowler micrometer. 
The magnitude of the DTH was expressed as the increment of the thickness  of the 
challenged  right  footpad as compared with the untreated left footpad. Responses  were 934  REGULATION  OF  HAPTEN-SPECIFIC T  CELL RESPONSE 
given in units of 10  -2 mm plus SE. Induction of DTH response to ABA was done exactly 
as described before (5). Each group consists of at least four mice. 
Induction of Suppressor Cells and Preparation of Suppressor Cells.  TNP-conjugated SC 
were prepared as described (19).  To induce suppressor cells, normal mice were injected 
intravenously with  5  ×  107 TNP-SC.  7 d  later,  these mice became the donors of Ts-1 
cells. Spleens from these animals were removed, and a single-cell suspension was prepared 
in  Hanks'  balanced  salt  solution  (HBSS).  The  cells  were  washed  twice  in  HBSS  and 
counted. To assay for the ability of such cells to inhibit TNP-specific DTH, 5 ×  107 viable 
cells were injected intravenously into normal recipients that were then primed subcuta- 
neously with TNBS and'challenged 6 d later as described earlier. 
Production of TsF-1.  Production  of TsF-1  was  accomplished precisely  as  described 
earlier (4). Briefly,  I  x  108 to 5  x  l0  s washed SC in  I  ml of HBSS were subjected to 
alternate snap freezing at -78°C and thawing at 37°C. This was repeated four times and 
followed by centrifugation at 10,000 g for 90 rain.  The supernates were adjusted to 5 x 
108 cell  equivalents/ml and frozen until  use  at -80°C. To test the ability  of TsF-1  to 
inhibit  TNP-specific  DTH,  the  extract  was  injected  intravenously  into  normal  mice 
beginning at the time of immunization with TNBS. 2 X 107 cell equivalents of the factors 
were administered each day for five successive  days.  2 d  later,  on day 7,  these animals 
were challenged and their footpad responses were measured. 
Induction of Ts-2.  To induce Ts-2,  TsF-1  (2  X  10  7 cell  equivalents/d)  was injected 
intravenously into normal mice for five successive days. On the first day of TsF-1 injection, 
the mice were also injected with 0.2 ml s.c. of 10 mM TNBS solution. On day 7, SC were 
assayed for Ts-2 activity by adoptive transfer to normal recipients that were immunized 
and challenged as described above. To assay for the ability of Ts-2 to inhibit the effector 
phase of the DTH reaction, 5 ×  107 putative Ts-2 were transferred into animals that had 
been immunized 6-7 d earlier. Within 2 h after cell transfer, all the recipients and their 
appropriate controls were challenged in the footpad with TNBS as described, and the 
increase in footpad swelling  determined 24 h postchallenge. 
Antiserum Treatment.  1 ×  l0  s SC were incubated with  1 ml of 1:20 dilution ofanti- 
Thy-1,2 hybridoma antibody for 45 min at 0 °C, washed once in HBSS, and then incubated 
again with  1 ml of a  1:6 dilution of low-tox rabbit complement (Accurate Chemical and 
Scientific  Corp., Westbury, NY) for 30 min at 37°C. The cells were then washed twice in 
HBSS, recounted, and resuspended for cell transfer. 
Plate Purification of Suppressor T Cells.  The spleens  from BALB/c mice injected with 
TNP-SC or TsF-1 were teased and washed in phosphate-buffered saline with 5% fetal calf 
serum, and erythrocytes were lysed with 0.83% Tris-NH4CI. As described elsewhere (13), 
the B cells were removed by incubation of the whole SC population on plastic petric dishes 
coated with affinity-purified rabbit anti-mouse Ig. The cell population that did not adhere 
to the anti-Ig-coated dishes contained 5-8% surface Ig-bearing cells as judged by immu- 
nofluorescence using fluoresceinated rabbit anti-mouse Ig. 
The cells  were then  incubated  on TNP-bovine serum  albumin  (BSA)-coated plastic 
petri dishes  as described previously (13).  After 1 h of incubation at room temperature, 
nonadherent cells were removed from such plates with three gentle washes.  After a  30- 
min incubation and cold shock at 40C,  the adherent cells were vigorously removed with 
three washes.  The cells  were washed once in  HBSS, counted, and resuspended  in  the 
appropriate volume for either transfer. 
Results 
Suppressor  Cells Induced by Intravenous  Injection  of TNP-SC Are T  Cells and Are 
Antigen Spec~c in their Action.  To investigate the regulation of T  cell-mediated 
DTH  reaction to TNP,  we first examined the  induction of suppressor cells  by 
intravenous injection of TNP-SC. The results  of this experiment are shown in 
Table  I.  As  can  be  seen,  intravenous  injection  of  TNP-SC  readily  induces 
suppressor cells in the animals, as demonstrated by adoptive transfer experiment TSURUFUJI,  BENACERRAF,  AND  SY  935 
TABLE  I 
Suppressor Cells lnduced by Intravenous Injection of TNP-SC Are T Cells and Are Antigen 
Spec~c in Their Action 
Inducers of  Number of cells trans-  Immuni-  Chal-  Footpad swell- 
Expt.  Ts*  ferred*  zation  0  lengeO  I  ing (x 10 -i  P value  I 
mm_ SE) 
1  --  m  TNBS  TNBS  30.0 _+ 3.5  -- 
TNP-SC  5 x  l0  T  TNBS  TNBS  13.0 _+ 2.9  <0.01 
--  --  --  TNBS  6.7 _+ 3.0  <0.01 
--  --  TNBS  TNBS  54.9 + 2.2  -- 
TNP-SC  5 x  107  TNBS  TNBS  28.7 + 2.5  <0.01 
TNP-SC  5 x  107  TNBS  TNBS  48.8 :t: 3.1  NS** 
(aO + complement) 
2  TNP-SC  5 x  107  TNBS  TNBS  29.9 + 3.0  <0.01 
(complement) 
--  --  --  TNBS  14.1 + 2.4  <0.01 
--  --  ABA  ABA  39.8 _+ 5.7  -- 
TNP-SC  5 x  107  ABA  ABA  49.5 + 3.1  NS 
--  --  --  ABA  7.0 +_ 1.0  <0.01 
* To induce suppressor T cells, normal BALB/c mice were injected with 5 x  107 TNP-SC i.v. 
* 7 d after intravenous injection of TNP-SC, these mice were the donors of suppressor T cells, and 
5 x  107 SC were transferred intravenously into groups of naive recipients. 
0 Within 2 h after receiving suppressor T cells, all the recipients and the appropriate controls were 
immunized subcutaneously with 0.2 ml of a  10 mM TNBS solution or 0.2 ml of a  10 mM ABA 
salt. 
In 6 d after immunization, all the experimental groups including the controls were challenged in 
the footpad as described in Materials and Methods. The increase in footpad swelling was measured 
24 h postchallenge. 
As compared with positive control. 
** Not significant. 
(experiment  1 and 2). In addition, in vitro treatment of these putative suppressor 
cells with a  monoclonal  anti-Thy-1  antibody and  complement  completely abro- 
gated  their  ability to  transfer  unresponsiveness.  Thus,  the  passive  transfer  of 
suppressor activity is a  T  ceil-dependent phenomenon.  Moreover, these suppres- 
sor T  cells are antigen specific, since Ts  induced by TNP-SC  failed to suppress 
the  development  of DTH  reaction to an  unrelated  antigen,  ABA  (experiment 
3). 
Suppressor T Cells Induced with TNP-SC Bind Antigen.  Earlier studies from our 
laboratories (1,  3) have provided  evidence for the participation of both antigen- 
binding and non-antigen-binding  suppressor T  cells in the ABA- and NP-specific 
suppressor T  cell pathway. To  further characterize the TNP-specific suppressor 
T  cells, we investigated their binding specificity using an experimental  protocol 
that has been used extensively in our earlier studies (13).  In the ABA system, we 
have  shown  that  antigen-specific Ts-1  cells can  be highly enriched  on  antigen- 
coated  plates.  Thus,  we  investigated  whether  TNP-specific  suppressor  T  cells 
can be enriched  on antigen-coated plates. 
The  results  of  such  an  experiment  are  shown  in  Table  II.  Incubation  of 
suppressor T  cells on petri dishes coated with TNP-BSA  resulted in a  significant 
enrichment  of suppressor  T  cells, as  compared  with  unfractionated  whole  SC. 936  REGULATION OF  HAPTEN-SPECIFIC  T  CELL  RESPONSE 
TABLE  II 
Fractionation of TNP-Specific Suppressor T Cells on Antigen-coated Plates 
Footpad swelling  Fractionation*  Numbertransferred,Of  cells  Immunization~  (x 10  -~ mm -+. SE)  II 
--  --  TNBS  32.2 + 3.1 
--  5 x  107  TNBS  11.0 + 4.0 
--  1 × 107  TNBS  26.2 __- 2.7 
TNP-BSA  5 x  105  TNBS  8.0 __. 1.6 
adherent 
TNP-BSA  5 x  106  TNBS  29.0 +_ 3.0 
nonadherent 
--  Challenge only  3.7 _+ 1.2 
* To induce suppressor T cells, normal BALB/c mice were injected with 5 × 107 
TNP-SC i.v. 7 d later, these mice were donors of suppressor T  cells. Before 
transfer to a naive recipient, they were then fractionated first on rabbit anti- 
mouse immunoglobulin plates to remove B cells and then again on TNP-BSA- 
coated plates to enrich for antigen-binding suppressor T cells as described in 
Materials and Methods. 
* Various numbers  of suppressor  T  cells were then  transferred to groups  of 
naive recipients. 
0 All recipients and their appropriate controls were immunized as described in 
Materials and Methods. 
16 d after immunization,  all the experimental  groups  including the controls 
were challenged in the footpad as described, and increases in footpad swelling 
were determined 24 h postchallenge. 
Furthermore, incubation of suppressor T  cells on plates coated with an unrelated 
antigen failed to show any significant enrichment (data not shown).  Therefore, 
similar to the results obtained in the ABA system, suppressor T  cells induced by 
intravenous inoculation of TNP-SC also bind antigen. 
Antigen-specific TsF Can Be Obtained f~vm TNP-SC-induced Ts and Is Strain Specific 
in its Action.  Since TsF have been shown to play a critical role in the propagation 
of suppressor pathways in  many different  experimental  systems (1-4),  we pre- 
pared TsF  using a  protocol  we had  used earlier  in  the  ABA  system (14).  This 
putative TsF was then  given to groups of mice that  had been  immunized with 
TNBS  to  test  for their  suppressor  activity.  The  results  of this experiment  are 
shown in Table III. 
Injection of TsF  obtained  from  BALB/c  (H-2  d)  mice inhibited  the  develop- 
ment of TNP-specific DTH  in  syngeneic BALB/c  mice. The same TsF prepa- 
ration also inhibited the development of DTH  reaction in H-2-identical DBA/2 
(H-2  d) mice. Nevertheless,  these TsF failed to suppress the  DTH  reaction in H- 
2-distinct C5 7BL/6 (H-2  b) and B 10. Br (H-2  k) mice. Furthermore, they also failed 
to  inhibit  DTH  reaction  in  A/J  mice (H-2  a) that  are identical  to the  BALB/c 
mice  in  the  I-C,D  subregion  of  the  H-2  complex.  Thus,  TNP-specific  TsF 
obtained  from  BALB/c  mice appears to be restricted  in  its action  by the  left- 
hand side of the major histocompatibility complex (MHC) complex (K, I-A, I-B, 
I-J, I-E). 
Failure  of TNP-specific  TsF  to  Induce  Ts-2  in  Naive  Mice.  One  of the  many 
features of antigen-specific TsF is their ability to induce second-order suppressor 
T  cells known as Ts-2 (1,  3,  4).  In addition,  our previous experiments suggest 
that  in  some experimental  systems the  participation  of antigen  in  conjunction TSURUFUJI,  BENACERRAF,  AND  SY  937 
TABLE  III 
Strain Spec~city of TNP-spec~c TsF-1 
Immuni-  Treatment*  Footpad swelling 
Strain  zation*  (x 10  -~ mm ±  SE)  0  P  value 
BALB/c  TNBS  --  37.7 __. 1.9 
(H-2  d)  TNBS  BALB/c TsF  16.0 +  2.3  <0.001 
--  --  5 ±  0.58 
DBA/2  TNBS  --  33.6 4- 1.5 
(H-2 d)  TNBS  BALB/c TsF  16.7 ±  1.3  <0.001 
--  --  4.6  ±  0.8 
C57BL/6  TNBS  --  30.0 ±  1.5 
(H-2 b)  TNBS  BALB/c TsF  30.3 ±  0.3  0.8  (NS)  I 
--  --  4.5  ±  0.5 
B10.BR  TNBS  --  23.7 ±  1.9 
(H-2  k)  TNBS  BALB/c TsF  22.5 ±  1.5  0.6  (NS) 
--  --  8.0  ±  1.7 
A/J  TNBS  --  31.7 ±  2.7 
(H-2  a)  TNBS  BALB/c TsF  27.5 ±  1.8  0.24  (NS) 
--  --  4±0.5 
* Different strains of mice were immunized with TNBS as described. 
* Suppressor factor (TsF-1) was prepared as described in Materials and Methods. TsF were injected 
intravenously  into  immunized animals  beginning on  the  day  of immunization  at  2  x  107  cell 
equivalent in 0.2 ml/d for five successive days. 
J 2  d  after the last injection of TsF, all the mice and their appropriate controls were challenged in 
the footpad with TNBS, and the increase in footpad swelling was determined 24 h postchallenge. 
! Not significant. 
with TsF is required for the induction of Ts-2 (i.e., GAT system). Nevertheless, 
in the ABA and NP systems, TsF alone appears to be able to induce Ts-2 in the 
absence of any antigen. To investigate whether TsF obtained from TNP-specific 
Ts will induce Ts-2 in naive mice, we injected TsF into groups of normal BALB/ 
c  mice  for  five successive days.  2  d  after  the  last  injection,  they became  the 
donors of putative Ts-2 cells. The results of a  typical experiment are shown in 
Table IV. 
TNP-specific TsF, when injected into sensitized mice beginning on the day of 
immunization,  inhibited the development of TNP-specific DTH reaction.  How- 
ever,  injection  of the  same TsF  into  naive mice failed to induce second-order 
suppressor cells in  these animals  as demonstrated  by adoptive transfer  experi- 
ment. Therefore, we proceeded to examine the possibility that the induction of 
Ts-2 in the TNP system may require the participation of antigen. 
Induction of Ts-2 in the TNP System But Not in the ABA System Requires Both TsF-I 
and Antigen.  To clarify whether the induction of Ts-2 in the TNP system may 
require antigen, we performed the following experiment. Normal BALB/c mice 
were  either  immunized  subcutaneously with  TNBS  or  injected  intravenously 
with TNP-specific TsF. In addition, a third group of mice were immunized with 
TNBS on the first day and were also given TsF for five successive days. 7 d later, 
2 d after the last injection of TsF, 5 X 10 7 SC from these animals were transferred 
to groups of naive recipients that were then immunized.  The results of such an 
experiment are shown in Table V. 
It was clearly demonstrated that SC obtained either from animals immunized 938  REGULATION OF  HAPTEN-SPECIFIC T  CELL  RESPONSE 
TABLE  IV 
TsF-1 Obtained  from TNP-spec~c Ts-1 Inhibits the Development of 
TNP-spec~c DTH, But the Injection of TsF-1 into Naive Animals 
Failed to Induce Second-order Ts-2 
Footpad swelling 
Immunization*  Treatment*  (x 10  -~ mm ___ SE)  P value 
TNBS  --  43.0 _  2.1  -- 
TNBS  TsF~  27.6 _ 4.3  <0.01 
Challenge only  15.3 +  1.2  <0.01 
Number of  Immuni-  Footpad swelling 
Inducer  cells trans-  (× 10  -~ mm +  P value 
of Ts-20  ferred  !  zation  SE) 
--  --  TNBS  46.00 _  3.0  -- 
TsF~  5 x  107  TNBS  49.25 + 3.7  NS 
Challenge only  10.33 _+ 1.4  <0.01 
* Normal BALB/c mice were immunized subcutaneously  with 0.2 ml of a 
10 mM TNBS solution. 
*TsF-1  prepared  as  described  in  Materials  and  Methods  was injected 
intravenously  into immunized animals beginning on the day of immuni- 
zation at 2 ×  107 cell equivalent  in 0.2 ml/d for 5 d. 
! To induce Ts-2, normal BALB/c mice were injected  with 2 x  107 i.v. 
cell equivalent  of TsF-1  in 0.2 ml/d for 5 d. On day 7, they were the 
donors of putative Ts-2 cells. 
n 5 ×  l0  T SC from animals treated with TsF-1  were transferred intrave- 
nously into groups of naive animals that were then immunized  subcuta- 
neously with TNBS. 
with  TNBS  alone  or  from  animals  injected  with  TsF  alone  were  unable  to 
transfer suppression.  However,  SC obtained from animals that had been immu- 
nized  with  TNBS  and  then  given  TsF  for  five  successive  days  showed  potent 
suppressor activity.  In contrast, experiment  3 in Table IV demonstrated  that,  in 
the ABA system, injection  of ABA-specific TsF-1,  without simultaneous  admin- 
istration  of antigen,  induced  significant  levels  of Ts-2  activity.  Thus,  we  con- 
cluded from these experiments,  that the induction of Ts-2 in the TNP,  but not 
the ABA system, required  the participation  of antigen in BALB/c  mice. 
Antigen  Specificity of the  Second Signal  Required for  the Activation  of Ts2.  To 
further  characterize  the nature  of the second signal required  for the activation 
of TNP-specific  Ts-2, we investigated  whether the delivery of the second signal 
was an antigen-specific event. The results of this experiment are shown in Table 
VI.  SC  obtained  from  animals  treated  with  TNP-specific  TsF-1  and  TNBS 
provided strong suppressor T  cell activity. In contrast, SC obtained from animals 
treated  with  TNP-specific  TsF-1  and  an  unrelated  antigen,  ABA,  failed  to 
activate TNP-specific Ts-2 cells.  Thus the second signal required  for the activa- 
tion of Ts-2 in the TNP  system was antigen specific. 
Suppressor  Cells  (Ts-2)  Induced  With  TsF-1  and  Antigen  Are  Efferent  Suppres- 
sors.  One of the main features of Ts-2 cells in other well-characterized  systems 
was their  ability  to suppress  at  the  efferent  stage of the  immune  response  (15, 
20).  Therefore,  we next  examined  whether  Ts-2  cells in the  TNP  system were 
also  efferent  suppressors.  In  these  experiments,  Ts-2  cells  were  induced  as 
described  earlier.  However,  in contrast  to earlier  experiments,  these  Ts-2  cells TSURUFUJI,  BENACERRAF,  AND  SY 
TABLE  V 
Induction of Ts-2 in the TNP System But Not in the ABA System Requires Both 
TsF-1 and Antigen 
939 
Expt.  Treatment of Ts-2  Number of  Immuni-  Footpad swelling 
Ts-2 trans-  P value 
donors*  ferred*  zation  e  (x 10 -~ mm ±  SE)  II 
1  --  --  TNBS  46.0 ±  3.08 
TsF  5 ×  107  TNBS  49.2 ±  3.7  NS  ~ 
TsF +  TNBS  5 ×  107  TNBS  19.3 ±  2.2  <0.01 
--  Challenge only  10.3 ±  1.4  <0.01 
--  --  TNBS  34.5 ±  2.5 
TNBS  5 ×  107  TNBS  33.2 ±  1.0  NS 
TsF  5 x  10  7  TNBS  37.6 ±  4.0  NS 
TNBS +  TsF  5 ×  107  TNBS  11.0 ±  2.6  <0.01 
Challenge only  6.0 ±  2.5  <0.01 
--  --  ABA  34.5 __. 1.5 
ABA  5 x  107  ABA  33.0 ±  3.2  NS 
TsF  5 x  107  ABA  17.7 +  1.5  0.01 
ABA x  TsF  5 x  107  ABA  23.0 ±  2.8  0.012 
--  Challenge only  7.0 ±  1.1  <0.01 
* Normal BALB/c mice were either immunized subcutaneously with 0.2  ml of a  10  mM TNBS 
solution, given TNP-specific TsF for five successive days, or were given TNBS and TsF both. For 
groups receiving both, TNBS was given only on the first day. 
* 7  d  later,  mice were donors of putative Ts-2 cells, and  5  ×  10  7 SC from various groups were 
transferred to groups of naive recipients that were then immunized subcutaneously. 
0 Mice were immunized subcutaneously with 0.2 ml of a  10 mM TNBS solution. 
II Challenge was done 6 d after immunization, and the increase in footpad swelling measured 24 h 
postchallenge. 
I Not significant. 
TABLE  VI 
Antigen Specificity of the Second Signal Required for the Activation of Ts-2 
Number of  Footpad swelling 
Treatment of Ts  cells trans-  Immuni-  (× 10  -2 mm ±  P value 
donors*  ferred*  zati°n°  SE)  ! 
--  --  TNBS  31.7 ±  2.6 
TsF  5 ×  107  TNBS  25.5 ±  1,2  0.8 (NS)  ~ 
TsF +  TNBS  5 x  107  TNBS  13.7  ±  1.6  0.001 
TsF +  ABA  5 x  107  TNBS  28.7 ±  2.6  0,5 (NS) 
Challenge only  5.3 ±  2.9  0.001 
* Normal BALB/c mice were either injected with TNP-specific TsF, given both TsF 
and TNBS, or given TNP-TsF and 0.2 ml of a  10 mM ABA solution, as described in 
Materials and Methods. 
* 7 d  later mice were the donors of putative Ts-2 cells and 5  x  107 SC from various 
groups were transferred to another group of naive recipients that were then immu- 
nized subcutaneously. 
0 Mice were immunized subcutaneously with 0.2 ml of a  10 mM TNBS solution. 
! Challenge was done 6  d  later and the increase in footpad swelling measured 24  h 
postchallenge. 
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were transferred into animals at the day of challenge rather than at the time of 
immunization, and the results are shown in Table VII. SC obtained from animals 
treated with TNP-specific TsF and TNBS were effective in suppressing the TNP- 
specific DTH reaction even when given at the day of challenge.  Therefore,  Ts- 
2 in the TNP system were efferent suppressors. 
Ts-2 Cells in the TNP System Bind Antigen.  The requirement for antigen in the 
activation of Ts-2 cells prompted us to investigate the binding specificity of these 
Ts-2.  Similar  to the experiment  described earlier,  we examined  whether  Ts-2 
cells can be enriched on antigen-coated plates. The results of such an experiment 
are shown in Table VIII.  As can be seen, similar to Ts-1  induced by TNP-SC, 
Ts-2 cells induced by TsF-1  and antigen could be readily enriched on antigen- 
coated plates. 
TABLE  VII 
Ts-2 Cells in the TNP System Are Efferent Suppressors 
Treatment of Ts-2  Number of  Immuni-  Day of  Footpad swelling 
donors*  cells trans-  (x 10  -~ mm +  P  value 
ferred*  zation  transfer  !  SE) 
--  --  TNBS  --  39.8 _  2.3  -- 
TsF  5 ×  107  TNBS  6  32.5 +_ 1.7  NS  ! 
TsF +  TNBS  5  x  107  TNBS  6  23.3 ±  2.7  <0.01 
Challenge only  5.7 ±  1.9  <0.01 
*  Normal BALB/c mice were either injected with TsF or with TsF and TNBS as described. 
*  7 d  later, mice were the donors of Ts-2 cells. 
g  5 x  107 Ts-2 cells were transferred into groups of recipients that had been immunized with TNBS 
6 d earlier. Within 1 h after transfer, all the recipients were challenged in the footpad with TNBS. 
t  Not significant. 
TABLE  VIII 
Fractionation of TNP-Specific Ts-2 on Antigen-coated Plates 
Number of  Footpad swelling 
Fractionation*  cells trans-  (x 10 -* mm ±  P  value 
ferred*  SE)  0 
--  --  31.7  +  2.0  -- 
--  5  x  107  9.7 +  2.7  <0.01 
B cells  5 x  107  23.0 -4-_  4.0  0.08 (NS)  ! 
T  cells  1 x  107  14.0 ±  2.8  <0.01 
TNP-BSA adherent  1 x  106  13.0 _+ 0.9  <0.01 
TNP-BSA nona-  5 x  106  21.2 ±  4.6  0.08 (NS) 
dherent 
*  Normal BALB/c mice were injected with TNBS and TsF-1  to induce 
Ts-2. Before transfer to naive recipients, Ts-2 were then fractionated 
first on rabbit anti-mouse lg plates to remove B cells and then again on 
TNP-BSA  plates  to  enrich for antigen-binding suppressor T  cells as 
described. 
*  Various number of suppressor T  cells were then transferred to groups 
of naive recipients that had been immunized with TNBS 6 d earlier. 
Within 2 h after transfer, all recipients were challenged in the footpad 
and the increase in footpad swelling determined 24 h postchallenge. 
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Discussion 
The results reported in this paper represent an extension of our earlier studies 
(4-7) on suppressor T  cells and their soluble products that regulate the devel- 
opment of DTH reaction to simple haptens. Using another simple hapten, TNBS, 
we have uncovered evidence of the involvement of a Ts-l-like cell in this system. 
Suppressor  T  cells induced with TNP-SC  can be enriched on antigen-coated 
plates, and are afferent suppressors and Lyt-1 ÷ (data not shown). Furthermore, 
they produced soluble TsF that are active in vivo. Thus, the Ts-1  cells in the 
TNP system are very similar to the Ts-1 cells in other systems. 
Nevertheless, three major differences were noted in the current studies. First, 
when we examined the strain specificity of TNP-specific TsF-1, to our surprise, 
we found that TsF-1 obtained from TNP-SC-induced suppressor T  cells is MHC- 
restricted. Second, injection of TNP-specific TsF-1  into naive mice was unable 
to  induce  Ts-2  unless  additional  antigen  was  injected.  Third,  the  Ts-2  cells 
induced by administration of both TsF-I and TNBS were antigen specific rather 
than antiidiotypic as were the ABA and NP systems (13,  15). 
We shall first compare these results in the TNP system with our earlier findings 
in the ABA and NP systems and then with results from other investigators. In 
contrast to results obtained earlier in the ABA and NP systems, in which Ts-1 
cells and their factors (TsF-1) could function without any genetic restriction (15, 
18), TsF-1  in the TNP system are MHC restricted in their activity. Thus, TsF-1 
obtained  from  BALB/c  (H-2  d)  mice were effective in  suppressing  the  DTH 
reaction in syngeneic BALB/c, H-2-identical DBA/2 (H-2a), and B 10.D2 (H-2  d) 
mice (data  not shown).  However, the same TsF-1  preparation  was  unable  to 
suppress DTH reaction in allogeneic B10.Br (H-2  k) or C57BL/6 (H-2  b) mice. It 
also failed to suppress in semiallogeneic A/J (H-2  a) mice. Therefore, the activity 
of TNP-specific TsF-1  appeared to be restricted by genes located in  the left- 
hand side of the MHC (H-2 K, I-A, I-B, I-J, I-E). Experiments are now in progress 
using H-2-congeneic mice to locate and explore the exact H-2 subregion(s) that 
govern the activity of TNP-specific TsF-1. 
The exact reason why TsF-1 in the ABA and NP systems are not H-2 restricted, 
while TNP-specific TsF are H-2 restricted, was puzzling. In our initial studies in 
the ABA  system, we  found  that  ABA-specific TsF-1  did  not  suppress  Igh-1- 
different mice directly. Our immediate interpretation was that TsF-I in the ABA 
system was restricted by Igh-l-linked genes. However, further analysis revealed 
that these factors induced Ts-2 cells appropriately in Igh-l-mismatched recipi- 
ents, and that the failure to observe suppression was due to the role of Igh-1- 
linked genes in  controlling idiotypic interactions further along the suppressor 
pathway (21). 
In the TNP system, we have so far only tested TNP-specific TsF-1 directly in 
different strains of animals.  We have not yet designed experiments to address 
the possibility that, despite the failure of TNP-specific TsF to induce suppression 
in allogeneic animals, they may still be able to induce a second population of Ts- 
2  cells in  these animals.  However, due to  the lack of appropriate  interaction 
further along the suppressor pathway, these Ts-2 cells may remain immunologi- 
cally silent. In addition, experiments are in progress to determine whether TNP° 
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characterization of these TsF, we have recently successfully fused these Ts-1 cells 
with a  T  cell thymoma,  BW5147, and generated  Ts-l-like T  cell hybridomas. 
Some of these hybridomas produce biologically active material that functions in 
vivo in  the  inhibition  of TNP-specific DTH and  in  vitro in  the generation  of 
TNP-specific cytotoxic T  cell response. 
The  finding that  TNP-specific TsF is  MHC restricted  in  its activity is not a 
new finding.  Many different groups,  including ourselves, have reported a  role 
for H-2 gene products in Ts or TsF activity. Miller et al. (22) have shown that 
suppression  of DTH  reaction  to  1-fluoro-2,4-dinitrobenzene  requires  identity 
between Ts donors and recipients at the H-2D locus. Moorhead (23) found that 
TsF  induced  with  dinitrobenzene  sulfonic  acid  (DNBS)  was  H-2K- or  H-2D- 
restricted in its interaction with its target cell. Asherson and Zambala (24) found 
that TsF induced with TNBS is restricted by the I-J subregions of the MHC gene 
products.  Thus,  H-2  genetic  restrictions  are  common  in  suppressor  systems, 
although  the  subregion  involved  and  the  restriction  site  appear  to  differ  in 
various experimental models. 
In an  attempt  to  further  characterize  the  suppressor  T  cell  pathway in  the 
TNP  system, we came across another  surprising  finding.  We found that  even 
though in vivo administration of TNP-specific TsF was able to suppress the DTH 
reaction, it was unable to induce Ts-2 in naive animals, unless additional antigen 
was provided. This requirement for antigen in the activation of Ts-2 cells could 
not be overcome by increasing the dose of TsF injected (i.e., using  1 x  108 cell 
equivalent/d for 5 d) or the number of cells transferred (i.e.,  1 ×  108 SC from a 
TsF-treated animal) (data not shown). 
The requirement for antigen in the induction of Ts-2 was first demonstrated 
in  the regulation  of antibody response to GAT by suppressor T  cells (8).  The 
reason  for  this  requirement  remains  ambiguous.  One  possibility  is  that  the 
interaction of antigen and TsF complex results in the formation of new antigenic 
determinants that favor the activation of suppressor cells. Another possibility is 
that the presence of antigen  may serve as a focusing signal to direct TsF to its 
appropriate target.  An additional intriguing possibility was raised by the recent 
finding of Ptak et al.  (25).  These investigators found that  interactions between 
two  molecules released  by two different  T  cell  subsets may yield a  complete 
factor with suppressor activity. In a  study very similar to ours, they found that 
sensitizing an animal  with TNBS results in the activation of Lyt-1 ÷ T  cells that 
secrete an antigen-binding  material,  while intravenous  injection of TNBS acti- 
vates Lyt-2  ÷ T  cells to produce a second subunit that does not see antigen. These 
two subunits  by themselves do not have any biological activity.  However, the 
interaction of these two molecules results in the formation of biologically active 
suppressor molecules.  It is possible that  our TsF-1  may represent  one of these 
two molecules, while the immunizing antigen activates another T  cell to release 
the second subunit, thus creating a functional suppressor factor with the ability 
to  induce  second-order  suppressor  T  cells  (Ts-2).  Experiments  are  now  in 
progress to address these issues. 
Our findings that Ts-2 induced in the TNP system are antigen specific rather 
than idiotype-specific is similar to the findings in the GAT system. However, it 
is in sharp contrast with our earlier findings in the ABA and  NP systems. The TSURUFUJI,  BENACERRAF, AND  SY  943 
most  obvious  difference between  these  systems  is  the  presence  of a  major 
dominant CRI  in  the ABA and NP systems (10,  16),  but not in the TNP and 
GAT systems (17).  It is reasonable to postulate that in systems where a  major 
idiotype is involved, there may be regulatory T cells preprogrammed to recognize 
certain idiotypic determinants; therefore, the role of idiotype-antiidiotype inter- 
action  is  predominant.  Such  interactions  represent  the  major  scheme of the 
network theory of immunoregulation, postulated by Jerne (26).  In systems like 
those  of TNP  and  GAT,  in  the  absence  of a  major  idiotype,  the  idiotypic 
determinants  that  are  unsually  involved  in  cellular  interaction  may  not  be 
"immunogenic" enough to  provide  the  necessary signal  for the  activation of 
antiidiotypic Ts-2. Thus, to complete the suppressor pathway, the system has to 
use an alternative suppressor pathway using both suppressor factors and antigen. 
If this  interpretation  is  correct,  the  second-order suppressor  cells  should  be 
antiidiotypic in all experimental systems that involve a  major idiotypic family, 
while in  systems lacking a  predominant idiotype, the Ts-2  induced should be 
idiotypic and should always require antigen.  Another interesting finding with 
respect to the role of idiotype in T  cell interaction is that in systems where a 
major idiotypic family does exist in the B cell compartment (e.g., ABA and NP), 
some of these determinants can also be detected in their T  cell subpopulations 
(4, 7). The most obvious explanation for these observations is that both B and T 
cells use some identical genetic information to encode for part of their receptors. 
Nevertheless,  it  is  also  possible  that  B  and  T  cells  use  different  genetic 
information to encode for their receptors. In some yet undefined mechanisms, 
however, B cells may be able to select or influence the generation of the T  cell 
repertoire. This would result in the generation of a T  cell subpopulation with 
receptors that are the mirror image of those present in B cells. 
Thus far, we have only studied the induction of Ts-1  and Ts-2  cells in  the 
TNP system. Yet, it has been established that an additional suppressor T  cell, 
Ts-3, is involved in the efferent limb of the suppressor T  cell circuit. Asherson 
and Zambala (24) and our laboratories (27) have shown that in the TNP and 
ABA systems, Ts-3  represents the final effect suppressors  which can mediate 
suppression in an antigen nonspecific function. Experiments are now in progress 
in our laboratories to further characterize this additional suppressor T  cell in 
the TNP system. 
Summary 
Suppressor T  cells (Ts-1) induced with trinitrophenyl (TNP)-conjugated syn- 
geneic spleen cells (TNP-SC) can be enriched on antigen-coated plates and are 
afferent suppressors.  In addition,  these suppressor cells produced soluble sup- 
pressor factors (TsF) that were active in vivo. Therefore, the Ts-1  cells in the 
TNP system are very similar to the Ts-1  cells in other systems we have studied 
earlier.  Further characterization of these TsF-1  revealed that TsF-1  obtained 
from TNP-SC-induced Ts-1  is major histocompatibility complex restricted in its 
activity. Injection of TNP-specific TsF-1  into naive mice did not induce Ts-2 
unless additional corresponding antigen was provided. Moreover, the Ts-2 cells 
induced by administration of both TsF-1 and trinitrobenzene sulfonic acid were 944  REGULATION  OF  HAPTEN-SPECIFIC  T  CELL  RESPONSE 
antigen specific rather than antiidiotypic. 
Received for publication 31 May 1983. 
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